Products

DocMak India

Company profiles that look agency-designed. Ready in minutes.

docmak.in Design / Graphic & Brand Design

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
One-time
No monthly subscription pricing
Creators
Docmak
@docmakdubai· 0 followers
Launched
20d ago
2026-10-27 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@docmakdubai
  • Launched on Product HuntLaunch

    Agency-quality company profile PDFs for Indian businesses

    Oct 27 · 20d agoLaunch page

    At the time: <5K visits/mo

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-10-17

KeywordMonthly volume
manufacturer kanpur170

Traffic data: Vaneform

Pricing

Free PDF
₹0
Minimum purchase 5 pages
Clean PDF
₹69.30 per page
Minimum purchase 5 pages

Trial: None · Observed 2026-11-06 · Pricing page

Pages & changes

Tracked since 2026-10-27

Key pages

Weekly snapshots
docmak.in/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much does DocMak India cost?
Free PDF: ₹0; Clean PDF: ₹69.30 per page. Observed 2026-11-06. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does DocMak India get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is DocMak India and what platforms does it support?
DocMak India is catalogued under Graphic & Brand Design: Company profiles that look agency-designed. Ready in minutes.. Supported platforms: Web.

Related products in this category

Design / Graphic & Brand Design

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.